Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 71335-1519

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 71335-1519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351519)

This appears to be a comparison of two different types of tablets, with information about their packaging, manufacturer, dosage, and a warning about possible side effects. The text also includes a suggestion for how to store the tablets.*

FDA Label Image

Quetiapine-fig1 (Quetiapine Fig1)

The text describes a figure labeled "Figure 1" which includes a graph (likely Kaplan-Mcier curves) representing the "Time to Recurrence of A Mood Event" for a study labeled "Study 7". The graph shows the proportion of patients who have experienced a relapse over time in relation to the number of weeks. The text includes a scale on the Y-axis that shows percentages from 0% to 100%. The X-axis is labeled as "Time (weeks)". There is also some illegible text present.*

FDA Label Image

Quetiapine-fig2 (Quetiapine Fig2)

The text provides a visualization of the Kaplan-Meier curves of Time to Recurrence of a Mood Event in Study 8. The graph displays the proportion of patients with relapse over time measured in weeks. No further context or information is given.*

FDA Label Image

Structure (Quetiapine Stru)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.